Phenotypic analysis of perennial airborne allergen-specific CD4 + T cells in atopic and non-atopic individuals

Clinical and Experimental Allergy

Volumn 41, Issue 11, 2011, Pages 1555-1567

  Crack, L R ^a   Chan, H W ^a   McPherson, T ^a,b   Ogg, G S ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

Atopic dermatitis; Cat allergy; Fel d 1; HLA class II tetramer; T cell epitope; T cells

Indexed keywords

ALLERGEN; CD27 ANTIGEN; CD28 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; HLA DPB1 ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 4; L SELECTIN;

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; ATOPY; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ALLERGENS; ANIMALS; CATS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; DERMATITIS, ATOPIC; EPITOPES, T-LYMPHOCYTE; FEMALE; GLYCOPROTEINS; HLA-DP BETA-CHAINS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; PEPTIDES; PHENOTYPE; PROTEIN MULTIMERIZATION; YOUNG ADULT;

EID: 80054051707     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03819.x     Document Type: Article

References (65)

1. Arshad SH, Karmaus W, Matthews Set al. Association of allergy-related symptoms with sensitisation to common allergens in an adult European population. J Invest Allergol Immunol 2001; 11:94-102.
2. Kaiser L, Grönlund H, Sandalova Tet al. Three-dimensional structure of Fel d 1, the major allergen in cat. Int Arch Allergy Immunol 2003; 132:25-6.
3. de Groot H, van Swieten P, van Leeuwen J, Lind P, Aalberse RC. Monoclonal antibodies to the major feline allergen Fel d I. Serologic and biologic activity of affinity-purified Fel d I and of Fel d I-depleted extract. J Allergy Clin Immunol 1988; 82:778-86.
4. van Neerven RJ, van de Pol MM, van Milligen FJ, Jansen HM, Aalberse RC, Kapsenberg ML. Characterization of cat dander-specific T lymphocytes from atopic patients. J Immunol 1994; 152:4203-10.
5. Counsell CM, Bond JF, Ohman JL, Greenstein JL, Garman R D. Definition of the human T-cell epitopes of Fel d 1, the major allergen of the domestic cat. J Allergy Clin Immunol 1996; 98:884-94.
6. Haselden BM, Kay AB, Larche M. Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med 1999; 189:1885-94.
7. Saarne T, Kaiser L, Gronlund H, Rasool O, Gafvelin G, van Hage-Hamsten M. Rational design of hypoallergens applied to the major cat allergen Fel d 1. Clin Exp Allergy 2005; 35:657-63.
8. Seppala U, Hagglund P, Wurtzen PAet al. Molecular characterization of major cat allergen Fel d 1: expression of heterodimer by use of a baculovirus expression system. J Biol Chem 2005; 280:3208-16.
9. Haselden BM, Larche M, Meng Qet al. Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid. J Allergy Clin Immunol 2001; 108:394-401.
10. Reefer AJ, Carneiro RM, Custis NJet al. A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen. J Immunol 2004; 172:2763-72.
11. Bateman EA, Ardern-Jones MR, Ogg GS. Identification of an immunodominant region of Fel d 1 and characterization of constituent epitopes. Clin Exp Allergy 2008; 38:1760-8.
12. *0101 tetramer-binding CD4+ T cells. J Allergy Clin Immunol 2006; 118:1350-6.
13. Varney VA, Edwards J, Tabbah K, Brewster H, Mavroleon G, Frew AJ. Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial. Clin Exp Allergy 1997; 27:860-7.
14. Ewbank PA, Murray J, Sanders K, Curran-Everett D, Dreskin S, Nelson HS.A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract. J Allergy Clin Immunol 2003; 111:155-61.
15. Nanda A, O'Connor M, Anand Met al. Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract. J Allergy Clin Immunol 2004; 114:1339-44.
16. Zhu D, Kepley CL, Zhang K, Terada T, Yamada T, Saxon A.A chimeric human-cat fusion protein blocks cat-induced allergy. Nat Med 2005; 11:446-9.
17. Larche M, Haselden BM, Oldfield WLet al. Mechanisms of T cell peptide epitope-dependent late asthmatic reactions. Int Arch Allergy Immunol 2001; 124:272-5.
18. Aslam A, Chan H, Warrell DA, Misbah S, Ogg GS. Tracking antigen-specific T-cells during clinical tolerance induction in humans. PLoS One 2010; 5:e11028.
19. Jones L, Malavige G, Jeffery Ket al. Tracking epitope-specific antiviral CD4+ T cell responses to a live attenuated vaccine reveals ongoing functional responses. Vaccine 2009; 27:7398-401.
20. Williams HC. Atopic dermatitis: new information from epidemiological studies. Br J Hosp Med 1994; 52:409-12.
21. Schmitt J, Langan S, Williams HC. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol 2007; 120:1389-98.
22. Bunce M, O'Neill CM, Barnardo MCet al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46:355-67.
23. Jones L, Black AP, Malavige GN, Ogg GS. Persistent high frequencies of varicella-zoster virus ORF4 protein-specific CD4+ T cells after primary infection. J Virol 2006; 80:9772-8.
24. Black AP, Ardern-Jones MR, Kasprowicz Vet al. Human keratinocyte induction of rapid effector function in antigen-specific memory CD4+ and CD8+ T cells. Eur J Immunol 2007; 37:1485-93.
25. Seneviratne SL, Jones L, Bailey AS, Black AP, Ogg GS. Severe atopic dermatitis is associated with a reduced frequency of IL-10 producing allergen-specific CD4+ T cells. Clin Exp Dermatol 2006; 31:689-94.
26. Beltrani VS. The role of house dust mites and other aeroallergens in atopic dermatitis. Clin Dermatol 2003; 21:177-82.
27. Thepen T, Langeveld-Wildschut EG, Bihari ICet al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 1996; 97:828-37.
28. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004; 113:651-7.
29. Harrington LE, Hatton RD, Mangan PRet al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6:1123-32.
30. Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006; 18:349-56.
31. Kawaguchi M, Onuchic LF, Li XDet al. Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J Immunol 2001; 167:4430-5.
32. Molet S, Hamid Q, Davoine Fet al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001; 108:430-8.
33. Bullens DM, Truyen E, Coteur Let al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res 2006; 7:135.
34. He R, Kim HY, Yoon Jet al. Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13. J Allergy Clin Immunol 2009; 124:761-70; e1.
35. Toda M, Leung DY, Molet Set al. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 2003; 111:875-81.
36. Koga C, Kabashima K, Shiraishi N, Kobayashi M, Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 2008; 128:2625-30.
37. Guttman-Yassky E, Lowes MA, Fuentes-Duculan Jet al. Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol 2008; 181:7420-7.
38. Liang SC, Tan XY, Luxenberg DPet al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006; 203:2271-9.
39. Zheng Y, Danilenko DM, Valdez Pet al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007; 445:648-51.
40. Nograles KE, Zaba LC, Shemer Aet al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 2009; 123:1244-52; e2.
41. Howell MD, Kim BE, Gao Pet al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007; 120:150-5.
42. Jung T, Stingl G. Atopic dermatitis: therapeutic concepts evolving from new pathophysiologic insights. J Allergy Clin Immunol 2008; 122:1074-81.
43. Kim BE, Leung DY, Boguniewicz M, Howell MD. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol 2008; 126:332-7.
44. Man MQ, Barish GD, Schmuth Met al. Deficiency of PPARbeta/delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation. J Invest Dermatol 2008; 128:370-7.
45. O'Regan GM, Irvine AD. The role of filaggrin loss-of-function mutations in atopic dermatitis. Curr Opin Allergy Clin Immunol 2008; 8:406-10.
46. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol 2008; 17:1063-72.
47. Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F.IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 2005; 174:3695-702.
48. Nograles KE, Zaba LC, Guttman-Yassky Eet al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 2008; 159:1092-102.
49. Sager N, Feldmann A, Schilling G, Kreitsch P, Neumann C. House dust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test. J Allergy Clin Immunol 1992; 89:801-10.
50. Meissner N, Kussebi F, Jung Tet al. A subset of CD8+ T cells from allergic patients produce IL-4 and stimulate IgE production in vitro. Clin Exp Allergy 1997; 27:1402-11.
51. Ferry B, Antrobus P, Huzicka I, Farrell A, Lane A, Chapel H. Intracellular cytokine expression in whole blood preparations from normals and patients with atopic dermatitis. Clin Exp Immunol 1997; 110:410-7.
52. Nakazawa M, Sugi N, Kawaguchi H, Ishii N, Nakajima H, Minami M. Predominance of type 2 cytokine-producing CD4+ and CD8+ cells in patients with atopic dermatitis. J Allergy Clin Immunol 1997; 99:673-82.
53. Sato A, Tsuji K, Yamamura Met al. Increased type 2 cytokine expression by both CD4+ CD45RO+ T cells and CD8+ CD45RO+ T cells in blood circulation is associated with high serum IgE but not with atopic dermatitis. J Invest Dermatol 1998; 111:1079-84.
54. Danke NA, Koelle DM, Kwok WW. Persistence of herpes simplex virus type 2 VP16-specific CD4+ T cells. Hum Immunol 2005; 66:777-87.
55. Macaubas C, Wahlstrom J, Galvao da Silva APet al. Allergen-specific MHC class II tetramer+ cells are detectable in allergic, but not in nonallergic, individuals. J Immunol 2006; 176:5069-77.
56. Reijonen H, Novak EJ, Kochik Set al. Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes 2002; 51:1375-82.
57. Lucas M, Day CL, Wyer JR et al. Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells. J Virol 2004; 78:7284-7.
58. Day CL, Seth NP, Lucas Met al. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Invest 2003; 112:831-42.
59. Appay V. The physiological role of cytotoxic CD4(+) T-cells: the holy grail? Clin Exp Allergy 2004; 138:10-3.
60. Appay V, Zaunders JJ, Papagno Let al. Characterization of CD4(+) CTLs ex vivo. J Immunol 2002; 168:5954-8.
61. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-12.
62. Seaman MS, Peyerl FW, Jackson SSet al. Subsets of memory cytotoxic T lymphocytes elicited by vaccination influence the efficiency of secondary expansion in vivo. J Virol 2004; 78:206-15.
63. Champagne P, Ogg GS, King ASet al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001; 410:106-11.
64. Zaph C, Uzonna J, Beverley SM, Scott P. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat Med 2004; 10:1104-10.
65. Fritsch RD, Shen X, Sims GP, Hathcock KS, Hodes RJ, Lipsky PE. Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J Immunol 2005; 175:6489-97.